| Literature DB >> 25062552 |
Gladys N Honein-AbouHaidar, Linda Rabeneck, Lawrence F Paszat, Rinku Sutradhar, Jill Tinmouth, Nancy N Baxter1.
Abstract
BACKGROUND: Since the publication of two randomized controlled trials (RCT) in 1996 demonstrating the effectiveness of fecal occult blood test (FOBT) in reducing colorectal cancer (CRC) mortality, several public health initiatives have been introduced in Ontario to promote FOBT participation. We examined the effect of these initiatives on FOBT participation and evaluated temporal trends in participation between 1994 and 2012.Entities:
Mesh:
Year: 2014 PMID: 25062552 PMCID: PMC4132913 DOI: 10.1186/1471-2407-14-537
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Figure 1Observed rates and segmented regression adjusted rates of fecal occult blood test (FOBT) participation per 1000, Ontario, 1994–2012. Observed rate = (FOBT completed per quarter/ population due for CRC screening per quarter)* 1000. Adjusted rate = (Exp (log rate-offset))*1000. Rates are connected by a binomial regression line. Dashed vertical lines indicate quarter when the following initiatives were enacted: RCT: Publication of the second and third randomized controlled trials in November 1996. CTFPHC: Publication of the Canadian Task Force on Preventive Health Care guidelines for CRC screening in February 2001. Announcement of PCP financial incentives in July 2005. CCC Program launch, April 2008. CCC Program 2-year anniversary, April 2010. The regression model was expressed as: .
Segmented regression analysis showing changes in intercept and changes in slope on FOBT participation rates following each initiative, 1994-2012
| Initiative (Segment) | Intercept * | Slope ^ | ||
|---|---|---|---|---|
| Change in Intercept (Δ) | 95% CI | Change in slope (Δ) | 95% CI | |
| Baseline (April 94-October 96) | −2.4¥‡ | (−3.9--0.9) | ||
| RCT (October 96-January 01) | −3.2 | (−13.1-7.9) | 6.1‡ | (4.3-7.9) |
| CTFPHC (January 01-July 05) | 6.8 | (−2.8-17.3) | 0.3 | (−0.6–1.3) |
| FI (July 05- April 08) | −1.5 | (−11.9–10.1) | 2.2‡ | (0.7– 3.8) |
| CCC launch (April 08-April 10) | 35.4‡ | (18.3–54.9) | −9.7‡ | (−12--7.4) |
| 2-year anniversary (April 10 –March 12) | 13.5 | (−1.6–30.9) | 7.2‡ | (3.9–10.5) |
*Difference between pre and post initiative intercepts interpreted as step change and calculated as QPC = (exp βINTi -1 )* 100.
^Difference between pre and post initiative slopes taking into account the trend before the initiative and calculated as QPC = (exp βINT*TIMEi -1 )* 100.
¥Baseline slope.
‡Statistically significant if 95% confidence interval does not cross zero.
RCT: Publication of the second and third randomized controlled trials in November 1996.
CTFPHC: Publication of the Canadian Task Force on Preventive Health Care guidelines for CRC screening in February 2001.
FI: Announcement of PCP financial incentives in July 2005.
CCC launch: ColonCancer Check program (CCC) Program launch, April 2008.
2 - year anniversary: ColonCancerCheck Program 2-year anniversary, April 2010.
Figure 2Observed rates of FOBT participation per 1000 and joinpoint location determined by Joinpoint regression analysis, Ontario, 1994–2012. Observed rate = (FOBT completed per quarter/population due for CRC screening per quarter)* 1000. * joinpoint location. Dashed vertical lines indicate quarter when the following initiatives were enacted: RCT: Publication of the second and third randomized controlled trials in November 1996. CTFPHC: Publication of the Canadian Task Force on Preventive Health Care guidelines for CRC screening in February 2001. Announcement of PCP financial incentives in July 2005. CCC Program launch, April 2008. CCC Program 2-year anniversary, April 2010.
Joinpoint regression analysis for FOBT participation in Ontario, 1994–2012 showing actual intercept at each joinpoint and actual slope between joinpoints
| Identified segment | Join-point | Intercept | Slope | ||
|---|---|---|---|---|---|
| Intercept £ | 95% CI | QPC ^ | 95% CI | ||
| April 1994-April 1997 | 0.3 | (0.15-0.47) | −1.7¥ | (−3.9–0.5) | |
| April 1997-July 2005 | Q 13 | 0.15‡ | (0.02-0.28) | 3.8‡ | (3.4–4.2) |
| July 2005-October 2009 | Q 46 | 0.03 | (−0.47-0.53) | 7.4‡ | (6.4–8.5) |
| October 2009-January 2010 | Q 59 | 62.1‡ | (59–64.9) | −5.5‡ | (−9.9--0.9) |
| January 2010-January 2011 | Q 64 | 0.01 | (−4.5-4.5) | 8.2‡ | (0.9-16) |
| January 2011-March 2012 | Q 68 | 6‡ | (3.1-8.9) | −1.4 | (−5.5–2.9) |
£Intercept at each joinpoint calculated as (exp β INTERCEPT i).
^Quarterly percent change (slope) between joinpoints calculated as (exp β SLOPEi -1)* 100.
¥Baseline trend.
‡Statistically significant if 95% confidence interval does not cross zero.